1.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 19 and over Sponsor: Other Protocol IDs: Oral Zinc RTC, H11-01758, NCT01468636
|
|
2.
|
Phase: Phase IV Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: CBKM120ZBR01, NCT01613677
|
|
3.
|
Phase: Phase III, Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: INTERTECC, R21CA162718-01, NCT01554397
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: EORTC-55994, 2008-003396-52, NCT00039338
|
|
5.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: E33022, NCT00122746
|
|
6.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 119 of 2003, NCT00193739
|
|
7.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: TMH/114/2003/CRACX TRIAL, NCT00193791
|
|
8.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00591, GOG-0219, CAN-NCIC-GOG-0219, CDR0000455555, U10CA027469, NCT00262821
|
|
9.
|
Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
|
|
10.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 006/027/ICI, NCT00532818
|
|
11.
|
Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 21 and over Sponsor: Other Protocol IDs: Cervix Cancer Research, NCT00548821
|
|
12.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: LACC001, NCT00614211
|
|
13.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
|
|
14.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: 2008049, NCT00806117
|
|
15.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039
|
|
16.
|
Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000654709, RTOG-0724, NCT00980954
|
|
17.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 to 60 Sponsor: Other Protocol IDs: TGOC-03, ECPSU-522231012, NCT01000415
|
|
18.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: GAND-emesis, 2009-014691-21, NCT01074697
|
|
19.
|
Phase: Phase III Type: Tissue collection/Repository, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000670125, GOG-0263, NCT01101451
|
|
20.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ROBOGYN - 1004, NCT01247779
|
|
21.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Project 803, NCT01279135
|
|
22.
|
Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2010-0952, NCT01365156
|
|
23.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000706698, ANZGOG-0902-GOG-0274/RTOG-1174, ANZGOG-0902-GOG-0274, NCT01414608
|
|
24.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: CCRTCICA-CXCA, NCT01461772
|
|
25.
|
Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 2011-1107, NCT01536392
|